U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07310407) titled 'Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)' on Dec. 16.
Brief Summary: evaluate the combined effects of Rutin and Vitamin C versus Vitamin C alone on selected oxidative stress markers, inflammation, hepatic steatosis regression, and associated metabolic parameters in patients with MASLD
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
NAFLD
Intervention:
DRUG: Rutin + Vitamin C
Type: Drug (Combination therapy) Details: Oral administration of two tablets containing 60 mg Rutin + 160 mg Vitamin C, taken three times daily for 12 weeks.
DRUG: Vitamin...